Shire plc : Statement re Proposal from Takeda Pharmaceutical Company Limited

NEXT STORY
Orion to sell its Orion Diagnostica division – Due to the transaction Orion updates its outlook
PREV STORY
Trinity Biotech plc to Announce First Quarter Fiscal Year 2018 Financial Results
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Rain Therapeutics Doses First Patient in Phase 2 Basket Trial of Milademetan for MDM2-Amplified Advanced Solid Tumors (MANTRA-2)

author_avatar
NASDAQ Market News

CytoDyn Submits Breakthrough Therapy Designation Application to FDA for Leronlimab as a Treatment for Metastatic Triple-Negative Breast Cancer (mTNBC); Fast Track Designation for mTNBC was received previously

author_avatar
NASDAQ Market News

Rexahn Pharmaceuticals Presents Final Data from the Supinoxin™ Phase I Clinical study and New Preclinical Data on RX-3117 at the 2017 European Society for Medical Oncology (ESMO) Congress

Supinoxin™ is well tolerated and shows preliminary evidence of clinical activity in difficult to ...

author_avatar
NASDAQ Market News